{"refrec":{"BRefID":236546,"RR":"European Journal of Cancer. Supplement (1990). Elsevier: United Kingdom.  ISSN 1359-6349","BEntID":228233,"PublicFlag":1,"CheckedFlag":0,"wosflag":1,"vabbflag":1,"RefStringPartII":". Elsevier: United Kingdom.  ISSN 1359-6349","DocTypID":16,"DocType":"Journal","MarineFlag":0,"FreshFlag":0,"BrackishFlag":0,"TerrestrialFlag":0,"Authorstring":null,"OrigTitleTranslFlag":0,"Authorstringtrunc":null,"Englishabstract":null,"AbstractOtherLang":null,"BibLvlCode":"S","StandardTitle":"European Journal of Cancer. Supplement (1990)","OrigTitleLangCode":"en","OrigTitleLangCodeExtended":"eng","OrigTitleLangID":15,"DateLastModified":{"date":"2024-12-10 01:33:17.368041","timezone_type":1,"timezone":"+01:00"},"UserAccessRight":null,"UserAccID":null,"AuthorKeywords":null,"OtherDescriptors":null,"Notes":null,"AnaPub":null,"MonPub":null,"DateUpdate":"2024-01-22","DateCreate":"2014-05-06","SecASFANote":null,"ConfID":null,"PeerRev":1,"VlizCoreFlag":1,"WoScode":null,"VABBcode":null,"OpenAcc":0},"refs":null,"anarec":null,"monrec":null,"serrec":{"SerID":236546,"ISSN":"1359-6349","Abbreviation":null,"PublID":null,"City":"United Kingdom","InpCentreCode":null,"ASFACode":null,"AntilopeFlag":0,"PerioID":null,"CurrentFlag":1,"PeerRevFlag":1,"DigISSN":null,"InputCentre":null,"Periodicity":null,"FromYear":null,"ToYear":null,"WoSFlag":1,"ISSNL":"0959-8049","EmbargoYears":null,"VABBFlag":1},"relations":null,"relationsRev":[{"XBRefID":217144,"RefStrFull":"European Journal of Cancer. Pergamon: Oxford; New York.  ISSN 0959-8049; e-ISSN 1879-0852","RelID":2,"RelationY":"Supplement Parent Entry","StandardTitle":"European Journal of Cancer"}],"addrec":null,"othpubs":null,"ownerships":null,"authors":null,"mapdetails":null,"datasets":null,"monographs":null,"monparts":null,"serparts":[{"BRefID":258000,"RR":"<b>Schöffski, P.; Grunwald, V.; Giaccone, G.; Salazar, R.; Majem, M.; Dumez, H.; Casado, E.; de las Heras, B.; Armand, J.</b> (2008). Outcome of three Phase I trials of the marine compound ES-285 (3 hour infusion) in patients with refractory solid tumors. <i>European journal of cancer. Supplement (1990) 6(12)</i>: 56-56. <a href=\"http://dx.doi.org/10.1016/S1359-6349(08)72108-6\" target=\"_blank\">dx.doi.org/10.1016/S1359-6349(08)72108-6</a>","StandardTitle":"Outcome of three Phase I trials of the marine compound ES-285 (3 hour infusion) in patients with refractory solid tumors","AuthorsString":"Schöffski, P. <i>et al.</i>","BibLvlCode":"AS"}],"BEntOpen":null,"BEntPrivate":null,"availability":null,"litstyles":null,"thespers":null,"arch2discl":null,"SERpubls":null,"MONpubls":null,"pictures":[],"thestermsPath":null,"thestermsASFA":null,"taxtermsASFA":null,"geotermsASFA":null,"collections":null,"conf":null,"proj":null,"Physdatasets":null,"spcols":null,"doi":null,"publs":[{"PublID":483,"PublName":"Elsevier","InsID":10940,"PersID":null,"INBOID":4047,"OrderNr":1}],"serparttypes":["A"],"monauthors":null,"MParts":null,"SParts":null,"hLibs":null,"langs":[{"BEntID":228233,"AbstractFlag":0,"LangID":15,"LangCode":"en","Lang":"English","DutchTerm":"Engels","LangCodeExtended":"eng"}],"urls":[{"URL":"https://doaj.org/toc/63c4d1439e15422686f6f1c38f17931b","externalID":null,"URLTypeCode":"DOAJ","URLID":125877,"URLTypID":48,"URLType":"DOAJ","URLPrefix":"https://doaj.org/"},{"URL":"https://www.journals.elsevier.com/european-journal-of-cancer-supplement","externalID":null,"URLTypeCode":null,"URLID":123208,"URLTypID":22,"URLType":"Journal home page","URLPrefix":null}],"thesterms":null,"taxterms":null,"geoterms":null,"othterms":null,"asfacodes":null,"asfa2codes":null,"thestermsFRIS":null,"taxtermsFRIS":null,"geotermsFRIS":null,"othtermsFRIS":null,"resmessage":"","complete":1,"sessions":{"newSesName":"T'Jampens, Roeland, R.","newSesDate":{"date":"2014-05-06 10:02:30.330000","timezone_type":3,"timezone":"Europe/Brussels"},"updSesName":"Bouchti, Zohra, Z.","updSesDate":{"date":"2024-01-22 08:20:48.030000","timezone_type":3,"timezone":"Europe/Brussels"}}}